Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 750 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Fady R.

Switzerland

USD 750 /hr

Pharma/Biotech Equity Research Consultant

Profile Summary

PharmD with years of experience in the pharmaceutical/biotech space, from leading a multimillion-dollar pharma company to being directly involved in drug development and consulting for hedge funds and other investors. I help hedge funds with the following: -Understanding and forecasting prescription patterns -Forecasting market size/share for new drugs -Understanding and forecasting growth for drug classes -Giving color to upcoming regulatory decisions (FDA) -Evaluating the potential of novel compounds in the early stages of development -Identifying unmet medical needs with significant potential

Subject Matter Expertise

• ★ Drug Development
• ☆ Biotechnology & Bioengineering
• ☆ Clinical Trials
• ☆ Regulatory Affairs
• ☆ Pharmaceutical Technology
• ☆ Cosmetic & Skincare Formulation

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Technical Writing, Copywriting, Newswriting

Research Market Research, Feasibility Study

Consulting Scientific and Technical Consulting

Data & AI Big Data Analytics

Work Experience

CEO, Founder

Centurion Life Sciences

October 2021 - Present

COO / Drug Development Lead

Riad Pharma

March 2017 - Present

Education

Master's degree (Pharmaceutical Sciences)

University of Geneva

- Present

Bachelor's degree (Pharmaceutical Sciences)

University of Geneva

- Present

Certifications

• Marketing Strategy

  UC Berkeley

  January 2021 - Present

Publications

NEWSPAPER ARTICLE

(2021). FDA Approval for Biogen’s Aducanumab: Controversy and Trends .

ONLINE RESOURCE

In vitro evaluation of the permeability of novel drug candidates in order to predict intestinal absorption .

Validation of Analytical Methods in the Pharmaceutical Industry: a brief Overview .